R&G PharmaStudies Co Ltd
SZSE:301333
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
R&G PharmaStudies Co Ltd
SZSE:301333
|
CN |
|
T
|
Telecom Digital Holdings Ltd
HKEX:6033
|
HK |
|
Venky's (India) Ltd
NSE:VENKEYS
|
IN |
|
Wealthy Way Group Ltd
HKEX:3848
|
HK |
|
Poonawalla Fincorp Ltd
NSE:POONAWALLA
|
IN |
R&G PharmaStudies Co Ltd
R&G PharmaStudies Co., Ltd. engages in the provision of clinical trial outsourcing services. The company is headquartered in Beijing, Beijing and currently employs 1,926 full-time employees. The company went IPO on 2022-08-02. The firm's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The firm operates its businesses primarily in the domestic market.
R&G PharmaStudies Co., Ltd. engages in the provision of clinical trial outsourcing services. The company is headquartered in Beijing, Beijing and currently employs 1,926 full-time employees. The company went IPO on 2022-08-02. The firm's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The firm operates its businesses primarily in the domestic market.
